DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
77 hedge funds and large institutions have $10.2M invested in DermTech, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 15 closing their positions.
289% more call options, than puts
Call options by funds: $443K | Put options by funds: $114K
0% more capital invested
Capital invested by funds: $10.2M → $10.2M (+$33.8K)
7% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 15
1% less funds holding
Funds holding: 78 → 77 (-1)
27% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$917K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$445K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$296K |
| 4 |
Millennium Management
New York
|
+$230K |
| 5 |
Jane Street
New York
|
+$109K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$3.91M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$75.7K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$48.1K |
| 4 |
SC
Saturna Capital
Bellingham,
Washington
|
-$40K |
| 5 |
OC
Oppenheimer & Co
New York
|
-$36.7K |
DMTK Hedge Fund Activity: Q4 2023 in Review
77 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q4 2023, worth a combined $10.2M — up 0.33% from $10.2M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of DMTK and 14 opened new positions — a net loss of 1 holder — while 22 trimmed existing stakes and 16 added.
The largest buyer was Morgan Stanley, adding an estimated $917K. The largest seller was RTW Investments, exiting entirely with an estimated $3.91M sold.
- 77 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q4 2023, down from 78 in Q3 2023.
- Funds reported $10.2M of DermTech, Inc. Common Stock stock for Q4 2023, up 0.33% quarter-over-quarter.
- 14 funds opened new DermTech, Inc. Common Stock positions in Q4 2023 and 15 closed out, a net change of -1 holder.
- The largest DermTech, Inc. Common Stock buyer in Q4 2023 was Morgan Stanley, an estimated $917K added.
- The largest DermTech, Inc. Common Stock seller in Q4 2023 was RTW Investments, an estimated $3.91M sold.
Based on aggregated 13F filings for Q4 2023.